586 related articles for article (PubMed ID: 33274815)
1. Prediction and Prevention of Cancer-Associated Thromboembolism.
Khorana AA; DeSancho MT; Liebman H; Rosovsky R; Connors JM; Zwicker J
Oncologist; 2021 Jan; 26(1):e2-e7. PubMed ID: 33274815
[TBL] [Abstract][Full Text] [Related]
2. Inpatient prophylaxis in cancer patients: where is the evidence?
Patell R; Zwicker JI
Thromb Res; 2020 Jul; 191 Suppl 1():S85-S90. PubMed ID: 32736785
[TBL] [Abstract][Full Text] [Related]
3. Risk of Thrombosis in Cancer: Clinical Factors and Role of Primary Prophylaxis.
Roopkumar J; Khorana AA
Cancer Treat Res; 2019; 179():55-68. PubMed ID: 31317480
[TBL] [Abstract][Full Text] [Related]
4. Successful Model for Guideline Implementation to Prevent Cancer-Associated Thrombosis: Venous Thromboembolism Prevention in the Ambulatory Cancer Clinic.
Holmes CE; Ades S; Gilchrist S; Douce D; Libby K; Rogala B; Parenteau E; Cushman M; Holm AK
JCO Oncol Pract; 2020 Sep; 16(9):e868-e874. PubMed ID: 32267798
[TBL] [Abstract][Full Text] [Related]
5. Asian venous thromboembolism guidelines: updated recommendations for the prevention of venous thromboembolism.
Liew NC; Alemany GV; Angchaisuksiri P; Bang SM; Choi G; DE Silva DA; Hong JM; Lee L; Li YJ; Rajamoney GN; Suviraj J; Tan TC; Tse E; Teo LT; Visperas J; Wong RS; Lee LH
Int Angiol; 2017 Feb; 36(1):1-20. PubMed ID: 27606807
[TBL] [Abstract][Full Text] [Related]
6. Venous thromboembolism in cancer patients.
Deng A; Galanis T; Graham MG
Hosp Pract (1995); 2014 Dec; 42(5):24-33. PubMed ID: 25485915
[TBL] [Abstract][Full Text] [Related]
7. Venous thromboembolism prevention in cancer outpatients.
Khorana AA
J Natl Compr Canc Netw; 2013 Nov; 11(11):1431-8. PubMed ID: 24225974
[TBL] [Abstract][Full Text] [Related]
8. Extended thromboprophylaxis in the acutely ill medical patient after hospitalization - a paradigm shift in post-discharge thromboprophylaxis.
Mahan CE; Burnett AE; Fletcher ML; Spyropoulos AC
Hosp Pract (1995); 2018 Feb; 46(1):5-15. PubMed ID: 29171776
[TBL] [Abstract][Full Text] [Related]
9. Risk factors for inpatient venous thromboembolism despite thromboprophylaxis.
Wang TF; Wong CA; Milligan PE; Thoelke MS; Woeltje KF; Gage BF
Thromb Res; 2014 Jan; 133(1):25-9. PubMed ID: 24300584
[TBL] [Abstract][Full Text] [Related]
10. American Society of Clinical Oncology guideline: recommendations for venous thromboembolism prophylaxis and treatment in patients with cancer.
Lyman GH; Khorana AA; Falanga A; Clarke-Pearson D; Flowers C; Jahanzeb M; Kakkar A; Kuderer NM; Levine MN; Liebman H; Mendelson D; Raskob G; Somerfield MR; Thodiyil P; Trent D; Francis CW;
J Clin Oncol; 2007 Dec; 25(34):5490-505. PubMed ID: 17968019
[TBL] [Abstract][Full Text] [Related]
11. Prophylaxis of venous thromboembolism in cancer patients.
Frere C; Doucet L; Farge D
Expert Rev Hematol; 2016 Jun; 9(6):535-9. PubMed ID: 27031534
[TBL] [Abstract][Full Text] [Related]
12. Primary prophylaxis of VTE in cancer outpatients.
Imberti D; Benedetti R
Thromb Res; 2016 Apr; 140 Suppl 1():S103-8. PubMed ID: 27067962
[TBL] [Abstract][Full Text] [Related]
13. Assessing the risk of venous thromboembolism in multiple myeloma.
Sanfilippo KM
Thromb Res; 2020 Jul; 191 Suppl 1():S74-S78. PubMed ID: 32736783
[TBL] [Abstract][Full Text] [Related]
14. Prophylaxis and treatment of venous thromboembolism in patients with cancer: the Saudi clinical practice guideline.
Al-Hameed F; Al-Dorzi HM; AlMomen A; Algahtani F; AlZahrani H; AlSaleh K; AlSheef M; Owaidah T; Alhazzani W; Neumann I; Wiercioch W; Brozek J; Schünemann H; Akl EA
Ann Saudi Med; 2015; 35(2):95-106. PubMed ID: 26336014
[TBL] [Abstract][Full Text] [Related]
15. Dalteparin thromboprophylaxis in cancer patients at high risk for venous thromboembolism: A randomized trial.
Khorana AA; Francis CW; Kuderer NM; Carrier M; Ortel TL; Wun T; Rubens D; Hobbs S; Iyer R; Peterson D; Baran A; Kaproth-Joslin K; Lyman GH
Thromb Res; 2017 Mar; 151():89-95. PubMed ID: 28139259
[TBL] [Abstract][Full Text] [Related]
16. Venous thromboembolism in the patient with cancer: focus on burden of disease and benefits of thromboprophylaxis.
Lyman GH
Cancer; 2011 Apr; 117(7):1334-49. PubMed ID: 21425133
[TBL] [Abstract][Full Text] [Related]
17. Joint 2022 European Society of Thoracic Surgeons and The American Association for Thoracic Surgery guidelines for the prevention of cancer-associated venous thromboembolism in thoracic surgery.
Shargall Y; Wiercioch W; Brunelli A; Murthy S; Hofstetter W; Lin J; Li H; Linkins LA; Crowther M; Davis R; Rocco G; Morgano GP; Schünemann F; Muti-Schünemann G; Douketis J; Schünemann HJ; Litle VR
Eur J Cardiothorac Surg; 2022 Dec; 63(1):. PubMed ID: 36519935
[TBL] [Abstract][Full Text] [Related]
18. Venous thromboembolism in cancer patients - risk scores and recent randomised controlled trials.
Thaler J; Ay C; Pabinger I
Thromb Haemost; 2012 Dec; 108(6):1042-8. PubMed ID: 22836491
[TBL] [Abstract][Full Text] [Related]
19. Venous Thromboembolism Prophylaxis: A Narrative Review With a Focus on the High-Risk Critically Ill Patient.
Lewis TC; Cortes J; Altshuler D; Papadopoulos J
J Intensive Care Med; 2019; 34(11-12):877-888. PubMed ID: 30165770
[TBL] [Abstract][Full Text] [Related]
20. Venous Thromboembolism Prophylaxis and Treatment in Patients With Cancer: ASCO Clinical Practice Guideline Update.
Key NS; Khorana AA; Kuderer NM; Bohlke K; Lee AYY; Arcelus JI; Wong SL; Balaban EP; Flowers CR; Francis CW; Gates LE; Kakkar AK; Levine MN; Liebman HA; Tempero MA; Lyman GH; Falanga A
J Clin Oncol; 2020 Feb; 38(5):496-520. PubMed ID: 31381464
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
